Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jude Samulski

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 23, 2025
New hope for older SMA patients with next-generation self-complementary AAV gene therapyHiroyuki Nakai, Erika L Finanger, Richard Jude Samulski
Current Gene Therapy|November 8, 2013
Biosafety of recombinant adeno-associated virus vectorsDavid J Dismuke, Liliane Tenenbaum, R Jude Samulski
Viruses|January 30, 2019
Adeno-associated Virus (AAV) versus Immune ResponseJoseph Rabinowitz, Ying Kai Chan, Richard Jude Samulski
Journal of Virology|December 13, 2002
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV productionDawn E Bowles, Joseph E Rabinowitz, R Jude Samulski
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 21, 2013
Parkinson's disease gene therapy: success by design meets failure by efficacyRaymond T Bartus, Marc S Weinberg, R Jude Samulski
Annual Review of Genetics|December 1, 2004
Integration of adeno-associated virus (AAV) and recombinant AAV vectorsDouglas M McCarty, Samuel M Young, R Jude Samulski
Neuropharmacology|April 3, 2012
Adeno-associated virus (AAV) gene therapy for neurological diseaseMarc S Weinberg, R Jude Samulski, Thomas J McCown
Therapeutic Delivery|July 27, 2012
Viral vectors and delivery strategies for CNS gene therapySteven J Gray, Kenton T Woodard, R Jude Samulski
Therapeutic Delivery|August 21, 2012
Recombinant adeno-associated virus: clinical application and development as a gene-therapy vectorPing-Jie Xiao, Thomas B Lentz, R Jude Samulski
Current Opinion in Molecular Therapeutics|October 2, 2010
Adeno-associated virus for the treatment of muscle diseases: toward clinical trialsNina DiPrimio, Scott W J McPhee, R Jude Samulski
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 23, 2025
New hope for older SMA patients with next-generation self-complementary AAV gene therapyHiroyuki Nakai, Erika L Finanger, Richard Jude Samulski
Current Gene Therapy|November 8, 2013
Biosafety of recombinant adeno-associated virus vectorsDavid J Dismuke, Liliane Tenenbaum, R Jude Samulski
Viruses|January 30, 2019
Adeno-associated Virus (AAV) versus Immune ResponseJoseph Rabinowitz, Ying Kai Chan, Richard Jude Samulski
Journal of Virology|December 13, 2002
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV productionDawn E Bowles, Joseph E Rabinowitz, R Jude Samulski
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 21, 2013
Parkinson's disease gene therapy: success by design meets failure by efficacyRaymond T Bartus, Marc S Weinberg, R Jude Samulski
Annual Review of Genetics|December 1, 2004
Integration of adeno-associated virus (AAV) and recombinant AAV vectorsDouglas M McCarty, Samuel M Young, R Jude Samulski
Neuropharmacology|April 3, 2012
Adeno-associated virus (AAV) gene therapy for neurological diseaseMarc S Weinberg, R Jude Samulski, Thomas J McCown
Therapeutic Delivery|July 27, 2012
Viral vectors and delivery strategies for CNS gene therapySteven J Gray, Kenton T Woodard, R Jude Samulski
Therapeutic Delivery|August 21, 2012
Recombinant adeno-associated virus: clinical application and development as a gene-therapy vectorPing-Jie Xiao, Thomas B Lentz, R Jude Samulski
Current Opinion in Molecular Therapeutics|October 2, 2010
Adeno-associated virus for the treatment of muscle diseases: toward clinical trialsNina DiPrimio, Scott W J McPhee, R Jude Samulski
Pageof 20